Cargando…
Omicron SARS-CoV-2 epidemic in England during February 2022: A series of cross-sectional community surveys
BACKGROUND: The Omicron wave of COVID-19 in England peaked in January 2022 resulting from the rapid transmission of the Omicron BA.1 variant. We investigate the spread and dynamics of the SARS-CoV-2 epidemic in the population of England during February 2022, by region, age and main SARS-CoV-2 sub-li...
Autores principales: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330654/ https://www.ncbi.nlm.nih.gov/pubmed/35915784 http://dx.doi.org/10.1016/j.lanepe.2022.100462 |
_version_ | 1784758214988922880 |
---|---|
author | Chadeau-Hyam, Marc Tang, David Eales, Oliver Bodinier, Barbara Wang, Haowei Jonnerby, Jakob Whitaker, Matthew Elliott, Joshua Haw, David Walters, Caroline E. Atchison, Christina Diggle, Peter J. Page, Andrew J. Ashby, Deborah Barclay, Wendy Taylor, Graham Cooke, Graham Ward, Helen Darzi, Ara Donnelly, Christl A. Elliott, Paul |
author_facet | Chadeau-Hyam, Marc Tang, David Eales, Oliver Bodinier, Barbara Wang, Haowei Jonnerby, Jakob Whitaker, Matthew Elliott, Joshua Haw, David Walters, Caroline E. Atchison, Christina Diggle, Peter J. Page, Andrew J. Ashby, Deborah Barclay, Wendy Taylor, Graham Cooke, Graham Ward, Helen Darzi, Ara Donnelly, Christl A. Elliott, Paul |
author_sort | Chadeau-Hyam, Marc |
collection | PubMed |
description | BACKGROUND: The Omicron wave of COVID-19 in England peaked in January 2022 resulting from the rapid transmission of the Omicron BA.1 variant. We investigate the spread and dynamics of the SARS-CoV-2 epidemic in the population of England during February 2022, by region, age and main SARS-CoV-2 sub-lineage. METHODS: In the REal-time Assessment of Community Transmission-1 (REACT-1) study we obtained data from a random sample of 94,950 participants with valid throat and nose swab results by RT-PCR during round 18 (8 February to 1 March 2022). FINDINGS: We estimated a weighted mean SARS-CoV-2 prevalence of 2.88% (95% credible interval [CrI] 2.76–3.00), with a within-round effective reproduction number (R) overall of 0.94 (0·91–0.96). While within-round weighted prevalence fell among children (aged 5 to 17 years) and adults aged 18 to 54 years, we observed a level or increasing weighted prevalence among those aged 55 years and older with an R of 1.04 (1.00–1.09). Among 1,616 positive samples with sublineages determined, one (0.1% [0.0–0.3]) corresponded to XE BA.1/BA.2 recombinant and the remainder were Omicron: N=1047, 64.8% (62.4–67.2) were BA.1; N=568, 35.2% (32.8–37.6) were BA.2. We estimated an R additive advantage for BA.2 (vs BA.1) of 0.38 (0.34–0.41). The highest proportion of BA.2 among positives was found in London. INTERPRETATION: In February 2022, infection prevalence in England remained high with level or increasing rates of infection in older people and an uptick in hospitalisations. Ongoing surveillance of both survey and hospitalisations data is required. FUNDING: Department of Health and Social Care, England. |
format | Online Article Text |
id | pubmed-9330654 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-93306542022-07-28 Omicron SARS-CoV-2 epidemic in England during February 2022: A series of cross-sectional community surveys Chadeau-Hyam, Marc Tang, David Eales, Oliver Bodinier, Barbara Wang, Haowei Jonnerby, Jakob Whitaker, Matthew Elliott, Joshua Haw, David Walters, Caroline E. Atchison, Christina Diggle, Peter J. Page, Andrew J. Ashby, Deborah Barclay, Wendy Taylor, Graham Cooke, Graham Ward, Helen Darzi, Ara Donnelly, Christl A. Elliott, Paul Lancet Reg Health Eur Articles BACKGROUND: The Omicron wave of COVID-19 in England peaked in January 2022 resulting from the rapid transmission of the Omicron BA.1 variant. We investigate the spread and dynamics of the SARS-CoV-2 epidemic in the population of England during February 2022, by region, age and main SARS-CoV-2 sub-lineage. METHODS: In the REal-time Assessment of Community Transmission-1 (REACT-1) study we obtained data from a random sample of 94,950 participants with valid throat and nose swab results by RT-PCR during round 18 (8 February to 1 March 2022). FINDINGS: We estimated a weighted mean SARS-CoV-2 prevalence of 2.88% (95% credible interval [CrI] 2.76–3.00), with a within-round effective reproduction number (R) overall of 0.94 (0·91–0.96). While within-round weighted prevalence fell among children (aged 5 to 17 years) and adults aged 18 to 54 years, we observed a level or increasing weighted prevalence among those aged 55 years and older with an R of 1.04 (1.00–1.09). Among 1,616 positive samples with sublineages determined, one (0.1% [0.0–0.3]) corresponded to XE BA.1/BA.2 recombinant and the remainder were Omicron: N=1047, 64.8% (62.4–67.2) were BA.1; N=568, 35.2% (32.8–37.6) were BA.2. We estimated an R additive advantage for BA.2 (vs BA.1) of 0.38 (0.34–0.41). The highest proportion of BA.2 among positives was found in London. INTERPRETATION: In February 2022, infection prevalence in England remained high with level or increasing rates of infection in older people and an uptick in hospitalisations. Ongoing surveillance of both survey and hospitalisations data is required. FUNDING: Department of Health and Social Care, England. Elsevier 2022-07-28 /pmc/articles/PMC9330654/ /pubmed/35915784 http://dx.doi.org/10.1016/j.lanepe.2022.100462 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Articles Chadeau-Hyam, Marc Tang, David Eales, Oliver Bodinier, Barbara Wang, Haowei Jonnerby, Jakob Whitaker, Matthew Elliott, Joshua Haw, David Walters, Caroline E. Atchison, Christina Diggle, Peter J. Page, Andrew J. Ashby, Deborah Barclay, Wendy Taylor, Graham Cooke, Graham Ward, Helen Darzi, Ara Donnelly, Christl A. Elliott, Paul Omicron SARS-CoV-2 epidemic in England during February 2022: A series of cross-sectional community surveys |
title | Omicron SARS-CoV-2 epidemic in England during February 2022: A series of cross-sectional community surveys |
title_full | Omicron SARS-CoV-2 epidemic in England during February 2022: A series of cross-sectional community surveys |
title_fullStr | Omicron SARS-CoV-2 epidemic in England during February 2022: A series of cross-sectional community surveys |
title_full_unstemmed | Omicron SARS-CoV-2 epidemic in England during February 2022: A series of cross-sectional community surveys |
title_short | Omicron SARS-CoV-2 epidemic in England during February 2022: A series of cross-sectional community surveys |
title_sort | omicron sars-cov-2 epidemic in england during february 2022: a series of cross-sectional community surveys |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330654/ https://www.ncbi.nlm.nih.gov/pubmed/35915784 http://dx.doi.org/10.1016/j.lanepe.2022.100462 |
work_keys_str_mv | AT chadeauhyammarc omicronsarscov2epidemicinenglandduringfebruary2022aseriesofcrosssectionalcommunitysurveys AT tangdavid omicronsarscov2epidemicinenglandduringfebruary2022aseriesofcrosssectionalcommunitysurveys AT ealesoliver omicronsarscov2epidemicinenglandduringfebruary2022aseriesofcrosssectionalcommunitysurveys AT bodinierbarbara omicronsarscov2epidemicinenglandduringfebruary2022aseriesofcrosssectionalcommunitysurveys AT wanghaowei omicronsarscov2epidemicinenglandduringfebruary2022aseriesofcrosssectionalcommunitysurveys AT jonnerbyjakob omicronsarscov2epidemicinenglandduringfebruary2022aseriesofcrosssectionalcommunitysurveys AT whitakermatthew omicronsarscov2epidemicinenglandduringfebruary2022aseriesofcrosssectionalcommunitysurveys AT elliottjoshua omicronsarscov2epidemicinenglandduringfebruary2022aseriesofcrosssectionalcommunitysurveys AT hawdavid omicronsarscov2epidemicinenglandduringfebruary2022aseriesofcrosssectionalcommunitysurveys AT walterscarolinee omicronsarscov2epidemicinenglandduringfebruary2022aseriesofcrosssectionalcommunitysurveys AT atchisonchristina omicronsarscov2epidemicinenglandduringfebruary2022aseriesofcrosssectionalcommunitysurveys AT digglepeterj omicronsarscov2epidemicinenglandduringfebruary2022aseriesofcrosssectionalcommunitysurveys AT pageandrewj omicronsarscov2epidemicinenglandduringfebruary2022aseriesofcrosssectionalcommunitysurveys AT ashbydeborah omicronsarscov2epidemicinenglandduringfebruary2022aseriesofcrosssectionalcommunitysurveys AT barclaywendy omicronsarscov2epidemicinenglandduringfebruary2022aseriesofcrosssectionalcommunitysurveys AT taylorgraham omicronsarscov2epidemicinenglandduringfebruary2022aseriesofcrosssectionalcommunitysurveys AT cookegraham omicronsarscov2epidemicinenglandduringfebruary2022aseriesofcrosssectionalcommunitysurveys AT wardhelen omicronsarscov2epidemicinenglandduringfebruary2022aseriesofcrosssectionalcommunitysurveys AT darziara omicronsarscov2epidemicinenglandduringfebruary2022aseriesofcrosssectionalcommunitysurveys AT donnellychristla omicronsarscov2epidemicinenglandduringfebruary2022aseriesofcrosssectionalcommunitysurveys AT elliottpaul omicronsarscov2epidemicinenglandduringfebruary2022aseriesofcrosssectionalcommunitysurveys |